​
​

Aprea Therapeutics (APRE) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Aprea Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$561.57K

Aprea Therapeutics Revenue by Period

Aprea Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Aprea Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Aprea Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$561.57K47.56%
2024-03-31$380.57K2603.87%
2023-12-31$14.07K-95.59%
2023-09-30$319.47K27.95%
2023-06-30$249.69K100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30--

Aprea Therapeutics generated $561.57K in revenue during Q2 2024, up 47.56% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Aprea Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADAGAdagene$18.11M$833.34K
ANABAnaptysBio$17.16M$30.02M
IKNAIkena Oncology$9.16M-
GBIOGeneration Bio$5.90M$4.09M
LUMOLumos Pharma$2.05M$488.00K
CBIOGyre Therapeutics$794.00K-
UNCYUnicycive Therapeutics$675.00K-
MGTADianthus Therapeutics$314.00K$72.00K
SILOSilo Pharma$72.10K$18.02K
ANEBAnebulo Pharmaceuticals--
RZLTRezolute--
APREAprea Therapeutics-$561.57K
FBRXForte Biosciences--
RNXTRenovoRx--
TPSTTempest Therapeutics--
ACRVAcrivon Therapeutics--
MLYSMineralys Therapeutics--
ERYPPHAXIAM Therapeutics--
SRZNSurrozen--

APRE Revenue FAQ

What is Aprea Therapeutics’s yearly revenue?

Aprea Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. APRE's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Aprea Therapeutics’s quarterly revenue?

Aprea Therapeutics's quarterly revenue for Q2 2024 was $561.57K, a 47.56% increase from the previous quarter (Q1 2024), and a 124.91% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $380.57K, a 2603.87% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). APRE's quarterly revenue for Q4 2023 was $14.08K, a -95.59% decrease from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Aprea Therapeutics’s revenue growth rate?

Aprea Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.